Answer
Oral disopyramide phosphate passes into breast milk; although no infant adverse effects were noted, clinical experience is limited, so use during lactation only if the clinician judges it essential, ideally with alternative feeding, and closely supervise the infant, particularly for anticholinergic effects, determining drug levels if necessary.
Sources for this answer
- Disopyramide Neon 250 mg Prolonged-Release TabletsNeon Healthcare Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked